Digestive System Lymphoma — Trials

Digestive System Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

119 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (25)

clinicaltrialsPublishedShowing 101–119 of 119 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00101205	Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma	terminated	Phase 1	40	National Cancer Institute (NCI)NIH	1	Feb 24, 2014	clinicaltrials
NCT00499811	Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction	completed	Phase 1	15	National Cancer Institute (NCI)NIH	1	Feb 24, 2014	clinicaltrials